Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced it has filed a voluntary petition under chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.

PLEASANTON, Calif., Oct. 9, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary select results for the third quarter ended September 30, 2024.

SHENZHEN, China, Oct. 8, 2024 /PRNewswire/ -- BAIYU Holdings, Inc. (Nasdaq: BYU) (the "Company" or "BAIYU"), a leading B2B bulk commodity e-commerce platform and supply chain service provider, today announced that it has filed timely a formal notice of appeal to a Hearings Panel of a Nasdaq Stock Market Listing Qualifications Staff's determination to delist the Company's securities from Nasdaq pursuant to Nasdaq Listing Rules 5101 and IM-5101-1. Following the receipt of notification from Nasdaq on October 4th, BAIYU determined to appeal the decision and intends to maintain that the Staff did not consider all relevant facts in making its delisting ...

Momentus Inc. (NASDAQ: MNTS) ("Momentus" or the "Company"), a provider of satellite buses and in-space infrastructure services including in-space transportation, hosted payloads, and other in-orbit services, was selected by NASA to provide launch services for future agency missions through its VADR (Venture-Class Acquisition of Dedicated and Rideshare) contract.